Format

Send to

Choose Destination
Mol Psychiatry. 2014 Jan;19(1):108-14. doi: 10.1038/mp.2012.157. Epub 2012 Nov 20.

Common variant at 16p11.2 conferring risk of psychosis.

Steinberg S1, de Jong S2, Mattheisen M3, Costas J4, Demontis D5, Jamain S6, Pietiläinen OP7, Lin K8, Papiol S9, Huttenlocher J10, Sigurdsson E11, Vassos E12, Giegling I13, Breuer R14, Fraser G15, Walker N16, Melle I17, Djurovic S17, Agartz I17, Tuulio-Henriksson A18, Suvisaari J18, Lönnqvist J18, Paunio T19, Olsen L20, Hansen T20, Ingason A20, Pirinen M21, Strengman E22; GROUP, Hougaard DM23, Orntoft T24, Didriksen M25, Hollegaard MV23, Nordentoft M26, Abramova L27, Kaleda V27, Arrojo M28, Sanjuán J29, Arango C30, Etain B31, Bellivier F32, Méary A31, Schürhoff F32, Szoke A31, Ribolsi M33, Magni V33, Siracusano A33, Sperling S34, Rossner M35, Christiansen C36, Kiemeney LA37, Franke B38, van den Berg LH39, Veldink J39, Curran S40, Bolton P40, Poot M22, Staal W41, Rehnstrom K42, Kilpinen H42, Freitag CM43, Meyer J44, Magnusson P45, Saemundsen E46, Martsenkovsky I47, Bikshaieva I47, Martsenkovska I47, Vashchenko O47, Raleva M48, Paketchieva K48, Stefanovski B48, Durmishi N48, Pejovic Milovancevic M49, Lecic Tosevski D49, Silagadze T50, Naneishvili N50, Mikeladze N50, Surguladze S51, Vincent JB52, Farmer A12, Mitchell PB53, Wright A53, Schofield PR54, Fullerton JM54, Montgomery GW55, Martin NG55, Rubino IA33, van Winkel R56, Kenis G57, De Hert M58, Réthelyi JM59, Bitter I59, Terenius L60, Jönsson EG60, Bakker S61, van Os J62, Jablensky A63, Leboyer M32, Bramon E64, Powell J8, Murray R65, Corvin A66, Gill M66, Morris D66, O'Neill FA67, Kendler K68, Riley B68; Wellcome Trust Case Control Consortium 2, Craddock N69, Owen MJ69, O'Donovan MC69, Thorsteinsdottir U70, Kong A1, Ehrenreich H9, Carracedo A71, Golimbet V27, Andreassen OA17, Børglum AD72, Mors O73, Mortensen PB74, Werge T75, Ophoff RA76, Nöthen MM77, Rietschel M14, Cichon S78, Ruggeri M79, Tosato S79, Palotie A80, St Clair D15, Rujescu D81, Collier DA82, Stefansson H1, Stefansson K70.

Author information

1
deCODE genetics, Reykjavik, Iceland.
2
Center for Neurobehavioral Genetics, UCLA, Los Angeles, CA, USA.
3
1] Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA [2] Institute for Genomic Mathematics, University of Bonn, Bonn, Germany [3] Department of Genomics, Life and Brain Center, University of Bonn, Bonn, Germany.
4
Galician Foundation of Genomic Medicine-SERGAS, Complexo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela, Spain.
5
1] Department of Biomedicine, Human Genetics, and Centre for Integrative Sequencing, iSEQ, Aarhus University, Aarhus, Denmark [2] The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
6
1] Fondation FondaMental, Créteil, France [2] INSERM U 955, Psychiatrie Génétique, Créteil, France.
7
1] Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland [2] Institute for Health and Welfare, Public Health Genomics Unit, Helsinki, Finland [3] Wellcome Trust Sanger Institute, Cambridge, UK.
8
Department of Neuroscience, NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and King's College, London, UK.
9
1] DFG Research Center for Molecular Physiology of the Brain (CMPB), Göttingen, Germany [2] Division of Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Göttingen, Germany.
10
1] deCODE genetics, Reykjavik, Iceland [2] Department of Medical Genetics, Institute of Human Genetics, University of Tübingen, Tübingen, Germany.
11
1] Department of Psychiatry, National University Hospital, Reykjavik, Iceland [2] School of Medicine, University of Iceland, Reykjavik, Iceland.
12
Social, Genetic and Developmental Psychiatry Research Centre, Institute of Psychiatry, King's College, London, UK.
13
Division of Molecular and Clinical Neurobiology, Department of Psychiatry, Ludwig-Maximilians University, Munich, Germany.
14
Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany.
15
Department of Mental Health, University of Aberdeen, Royal Cornhill Hospital, Aberdeen, UK.
16
Ravenscraig Hospital, Greenock, UK.
17
Division of Mental Health and Addiction, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo University Hospital, Oslo, Norway.
18
Department of Mental Health and Substance Abuse Services, National Institute for Health and Welfare, Helsinki, Finland, and Department of Psychiatry, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
19
Public Health Genomics Unit, National Institute for Health and Welfare THL, Helsinki, Finland, and Department of Psychiatry, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
20
Institute of Biological Psychiatry, Mental Health Centre Sct Hans, Copenhagen University, Roskilde, Denmark.
21
Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
22
Department of Medical Genetics, University Medical Centre Utrecht, Utrecht, the Netherlands.
23
Section of Neonatal Screening and Hormones, Department of Clinical Biochemistry, Immunology and Genetics, Statens Serum Institut, Copenhagen, Denmark.
24
Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
25
Synaptic transmission, H. Lundbeck A/S, Copenhagen, Denmark.
26
1] The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark [2] Psychiatric Center Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark.
27
Mental Health Research Center, Russian Academy of Medical Sciences, Moscow, Russia.
28
Service of Psychiatry, Complexo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela, Spain.
29
Unit of Psychiatry, Faculty of Medicine, University of Valencia, Network Center of Biomedical Research on Mental Health (CIBERSAM), Valencia, Spain.
30
Hospital General Universitario Gregorio Marañón, IiSGM, Universidad Complutense, CIBERSAM, Madrid, Spain.
31
1] Fondation FondaMental, Créteil, France [2] INSERM U 955, Psychiatrie Génétique, Créteil, France [3] AP-HP, Hôpital H. Mondor - A. Chenevier, Pôle de Psychiatrie, Creteil France.
32
1] Fondation FondaMental, Créteil, France [2] INSERM U 955, Psychiatrie Génétique, Créteil, France [3] AP-HP, Hôpital H. Mondor - A. Chenevier, Pôle de Psychiatrie, Creteil France [4] Université Paris Est, Faculté de Médecine, Creteil, France.
33
Section of Psychiatry, Department of Neuroscience, University of Rome-Tor Vergata, Rome, Italy.
34
Division of Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Göttingen, Germany.
35
1] DFG Research Center for Molecular Physiology of the Brain (CMPB), Göttingen, Germany [2] Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany.
36
Nordic Bioscience, Herlev, Denmark.
37
Department of Epidemiology and Biostatistics and Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
38
Departments of Human Genetics and Psychiatry, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
39
Department of Neurology, Rudolf Magnus Institute of Neuroscience, University Medical Center, Utrecht, the Netherlands.
40
1] Social, Genetic and Developmental Psychiatry Research Centre, Institute of Psychiatry, King's College, London, UK [2] Department of Child and Adolescent Psychiatry, Institute of Psychiatry, King's College, London UK.
41
Department of Cognitive Neuroscience, Radboud University Nijmegen, Nijmegen, The Netherlands.
42
1] Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland [2] Wellcome Trust Sanger Institute, Cambridge, UK.
43
Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University of Frankfurt am Main, Frankfurt am Main, Germany.
44
Department of Neurobehavioural Genetics, University of Trier, Trier, Germany.
45
Department of Child and Adolescent Psychiatry, National University Hospital, Reykjavik, Iceland.
46
State Diagnostic and Counseling Centre, Kopavogur, Iceland.
47
Department of Child, Adolescent Psychiatry and Medical-Social Rehabilitation, Ukrainian Research Institute of Social, Forensic Psychiatry and Drug Abuse, Kyiv, Ukraine.
48
Department of Child and Adolescent Psychiatry, University of Skopje, Skopje, Macedonia.
49
1] Institute of Mental Health, Belgrade, Serbia [2] Medical Faculty, University of Belgrade, Belgrade, Serbia.
50
Department of Psychiatry and Drug Addiction, Tbilisi State Medical University (TSMU), Tbilisi, Georgia.
51
Social and Affective Neuroscience Lab, Ilia State University, Tbilisi, Georgia.
52
Molecular Neuropsychiatry and Development Laboratory, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
53
1] Black Dog Institute, Prince of Wales Hospital, Randwick, NSW, Australia [2] School of Psychiatry, University of New South Wales, Sydney, NSW, Australia.
54
1] Neuroscience Research Australia, Barker Street, Sydney, NSW, Australia [2] School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia.
55
Queensland Institute of Medical Research, Brisbane, QLD, Australia.
56
1] University Psychiatric Center, Catholic University Leuven, Kortenberg, Belgium [2] Department of Psychiatry and Psychology, School of Mental Health and Neuroscience, European Graduate School of Neuroscience (EURON), South Limburg Mental Health Research and Teaching Network (SEARCH), Maastricht University Medical Center, Maastricht, The Netherlands.
57
Department of Psychiatry and Psychology, School of Mental Health and Neuroscience, European Graduate School of Neuroscience (EURON), South Limburg Mental Health Research and Teaching Network (SEARCH), Maastricht University Medical Center, Maastricht, The Netherlands.
58
University Psychiatric Center, Catholic University Leuven, Kortenberg, Belgium.
59
Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary.
60
Department of Clinical Neuroscience, HUBIN project, Karolinska Institutet and Hospital, Stockholm, Sweden.
61
Rudolf Magnus Institute of Neuroscience, Department of Psychiatry, University Medical Center, Utrecht, The Netherlands.
62
Department of Psychiatry, Maastricht University Medical Centre, Maastricht, The Netherlands.
63
Centre for Clinical Research in Neuropsychiatry (CCRN), Graylands Hospital, the University of Western Australia, Perth, WA, Australia.
64
Mental Health Sciences Unit and Institute of Cognitive Neuroscience, University College London, London, UK.
65
Department of Psychosis Studies, NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and King's College, London, UK.
66
Neuropsychiatric Genetics Research Group, School of Medicine, Trinity College, Dublin, Ireland.
67
Department of Psychiatry, Queens University, Belfast, UK.
68
1] Department of Human Genetics, Virginia Commonwealth University, Richmond, VA, USA [2] Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, VA, USA [3] Department of Psychiatry, Virginia Commonwealth University, Richmond, VA, USA.
69
MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Cardiff, UK.
70
1] deCODE genetics, Reykjavik, Iceland [2] School of Medicine, University of Iceland, Reykjavik, Iceland.
71
Genomic Medicine Group - Galician Foundation of Genomic Medicine-Biomedical Network Research Centre on Rare Diseases (CIBERER), University of Santiago de Compostela, Santiago de Compostela, Spain.
72
1] Department of Biomedicine, Human Genetics, and Centre for Integrative Sequencing, iSEQ, Aarhus University, Aarhus, Denmark [2] The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark [3] Centre for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark.
73
1] The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark [2] Centre for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark.
74
1] The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark [2] National Centre for Register-based Research, Aarhus University, Aarhus, Denmark.
75
1] The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark [2] Institute of Biological Psychiatry, Mental Health Centre Sct Hans, Copenhagen University, Roskilde, Denmark.
76
1] Center for Neurobehavioral Genetics, UCLA, Los Angeles, CA, USA [2] Rudolf Magnus Institute of Neuroscience, Department of Psychiatry, University Medical Center, Utrecht, The Netherlands.
77
1] German Center for Neurodegenerative Disorders (DZNE), Bonn Germany [2] Institute of Human Genetics, University of Bonn, Bonn Germany.
78
1] Department of Genomics, Life and Brain Center, University of Bonn, Bonn, Germany [2] Institute of Human Genetics, University of Bonn, Bonn Germany [3] Institute of Neurosciences and Medicine (INM-1), Juelich, Germany.
79
Section of Psychiatry, University of Verona, Verona, Italy.
80
1] Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland [2] Wellcome Trust Sanger Institute, Cambridge, UK [3] Program in Medical and Population Genetics and Genetic Analysis Platform, The Broad Institute of MIT and Harvard, Cambridge, MA, USA [4] Department of Medical Genetics, University of Helsinki and University Central Hospital, Helsinki, Finland.
81
1] Division of Molecular and Clinical Neurobiology, Department of Psychiatry, Ludwig-Maximilians University, Munich, Germany [2] Department of Psychiatry, University of Halle-Wittenberg, Halle, Germany.
82
1] Social, Genetic and Developmental Psychiatry Research Centre, Institute of Psychiatry, King's College, London, UK [2] Eli Lilly and Co. Ltd, Erl Wood Manor, Windlesham, Surrey, UK.

Abstract

Epidemiological and genetic data support the notion that schizophrenia and bipolar disorder share genetic risk factors. In our previous genome-wide association study, meta-analysis and follow-up (totaling as many as 18 206 cases and 42 536 controls), we identified four loci showing genome-wide significant association with schizophrenia. Here we consider a mixed schizophrenia and bipolar disorder (psychosis) phenotype (addition of 7469 bipolar disorder cases, 1535 schizophrenia cases, 333 other psychosis cases, 808 unaffected family members and 46 160 controls). Combined analysis reveals a novel variant at 16p11.2 showing genome-wide significant association (rs4583255[T]; odds ratio=1.08; P=6.6 × 10(-11)). The new variant is located within a 593-kb region that substantially increases risk of psychosis when duplicated. In line with the association of the duplication with reduced body mass index (BMI), rs4583255[T] is also associated with lower BMI (P=0.0039 in the public GIANT consortium data set; P=0.00047 in 22 651 additional Icelanders).

PMID:
23164818
PMCID:
PMC3872086
DOI:
10.1038/mp.2012.157
[Indexed for MEDLINE]
Free PMC Article

Publication types, MeSH terms, Grant support

Publication types

MeSH terms

Grant support

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center